Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers

بواسطة Gotti, Manuel, Defrancesco, Irene, D’Angelo, Mario, Basso, Sabrina, Crotto, Luca, Marinelli, Alfredo, Maccalli, Cristina, Iaconianni, Vincenzo
الحاوية / القاعدة Front Immunol (2020)

High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial

بواسطة Marinelli, Alfredo, Lamberti, Giuseppe, Cerbone, Luigi, Cordua, Nadia, Buonerba, Carlo, Peluso, Gianfranco, Di Lorenzo, Giuseppe, De Placido, Sabino
الحاوية / القاعدة Medicine (Baltimore) (2018)

Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study

بواسطة Addeo, Raffaele, Lamberti, Giuseppe, Simonetti, Giorgia, Iodice, Patrizia, Marinelli, Alfredo, Montella, Liliana, Cappabianca, Salvatore, Gaviani, Paola, Caraglia, Michele, Prete, Salvatore Del, Silvani, Antonio
الحاوية / القاعدة CNS Oncol (2019)

High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism

بواسطة Cirillo, Alessandra, Di Salle, Anna, Petillo, Orsolina, Melone, Mariarosa AB, Grimaldi, Giovanna, Bellotti, Alfredo, Torelli, Giovanni, de’ Santi, Maria Serena, Cantatore, Giovanna, Marinelli, Alfredo, Galderisi, Umberto, Peluso, Gianfranco
منشور في 2014

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial

بواسطة Buonerba, Carlo, De Placido, Pietro, Bruzzese, Dario, Pagliuca, Martina, Ungaro, Paola, Bosso, Davide, Ribera, Dario, Iaccarino, Simona, Scafuri, Luca, Liotti, Antonietta, Romeo, Valeria, Izzo, Michela, Perri, Francesco, Casale, Beniamino, Grimaldi, Giuseppe, Vitrone, Francesca, Brunetti, Arturo, Terracciano, Daniela, Marinelli, Alfredo, De Placido, Sabino, Di Lorenzo, Giuseppe
الحاوية / القاعدة Front Pharmacol (2018)